NADMED appoints James Lee as CEO
NADMED has appointed James Lee as its new Chief Executive Officer, effective from the beginning of...
The first $30,000 NADMED Award to Cleveland Clinic
We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the...
NADMED Partners with London-based Altheome Labs
NADMED has partnered with London-based Altheome Labs to expand access to advanced NAD testing in...
Could NAD Serve as a Biomarker for Stroke Recovery?
A new abstract, presented at the American Stroke Association’s Conference, explores how NAD and...
Research Links NAD+ Decline to Alzheimer’s Disease
A study in Cell Reports Medicine shows significantly lower NAD+ levels in the brains of...
Groundbreaking Study Shows NAD⁺ Restores Memory in Alzheimer’s Models
A newly published study reveals that NAD⁺ can restore memory in Alzheimer’s disease models by...






